vs

Side-by-side financial comparison of MidWestOne Financial Group, Inc. (MOFG) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $61.3M, roughly 1.4× MidWestOne Financial Group, Inc.). MidWestOne Financial Group, Inc. runs the higher net margin — 27.8% vs -38.1%, a 65.8% gap on every dollar of revenue. On growth, MidWestOne Financial Group, Inc. posted the faster year-over-year revenue change (35.9% vs 20.2%). Over the past eight quarters, MidWestOne Financial Group, Inc.'s revenue compounded faster (37.2% CAGR vs 24.8%).

MidWestOne Financial Group, Inc. is a bank holding company headquartered in Iowa City, Iowa. The bank operates 56 branches. It is the 3rd largest bank headquartered in Iowa. It operates in Iowa, Minnesota, Wisconsin, Colorado, and Florida.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

MOFG vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.4× larger
PRCT
$83.1M
$61.3M
MOFG
Growing faster (revenue YoY)
MOFG
MOFG
+15.7% gap
MOFG
35.9%
20.2%
PRCT
Higher net margin
MOFG
MOFG
65.8% more per $
MOFG
27.8%
-38.1%
PRCT
Faster 2-yr revenue CAGR
MOFG
MOFG
Annualised
MOFG
37.2%
24.8%
PRCT

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
MOFG
MOFG
PRCT
PRCT
Revenue
$61.3M
$83.1M
Net Profit
$17.0M
$-31.6M
Gross Margin
64.9%
Operating Margin
35.1%
-4.1%
Net Margin
27.8%
-38.1%
Revenue YoY
35.9%
20.2%
Net Profit YoY
117.8%
-27.9%
EPS (diluted)
$0.82
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MOFG
MOFG
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$61.3M
$83.3M
Q2 25
$60.2M
$79.2M
Q1 25
$57.6M
$69.2M
Q4 24
$48.9M
$68.2M
Q3 24
$37.5M
$58.4M
Q2 24
$57.9M
$53.4M
Net Profit
MOFG
MOFG
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$17.0M
$-21.4M
Q2 25
$10.0M
$-19.6M
Q1 25
$15.1M
$-24.7M
Q4 24
$16.3M
$-18.9M
Q3 24
$-95.7M
$-21.0M
Q2 24
$15.8M
$-25.6M
Gross Margin
MOFG
MOFG
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
MOFG
MOFG
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
35.1%
-27.8%
Q2 25
20.9%
-28.0%
Q1 25
34.0%
-39.7%
Q4 24
43.1%
-28.9%
Q3 24
-347.0%
-38.4%
Q2 24
36.0%
-50.3%
Net Margin
MOFG
MOFG
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
27.8%
-25.7%
Q2 25
16.6%
-24.7%
Q1 25
26.3%
-35.8%
Q4 24
33.4%
-27.6%
Q3 24
-255.1%
-35.9%
Q2 24
27.3%
-48.0%
EPS (diluted)
MOFG
MOFG
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$0.82
$-0.38
Q2 25
$0.48
$-0.35
Q1 25
$0.73
$-0.45
Q4 24
$1.30
$-0.34
Q3 24
$-6.05
$-0.40
Q2 24
$1.00
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MOFG
MOFG
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$98.0M
$51.7M
Stockholders' EquityBook value
$606.1M
$347.7M
Total Assets
$6.2B
$487.1M
Debt / EquityLower = less leverage
0.16×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MOFG
MOFG
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
MOFG
MOFG
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$98.0M
$51.6M
Q2 25
$112.3M
$51.5M
Q1 25
$111.4M
$51.5M
Q4 24
$113.4M
$51.5M
Q3 24
$115.1M
$51.4M
Q2 24
$114.8M
$51.4M
Stockholders' Equity
MOFG
MOFG
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$606.1M
$380.3M
Q2 25
$589.0M
$385.8M
Q1 25
$579.6M
$389.2M
Q4 24
$559.7M
$402.2M
Q3 24
$562.2M
$241.2M
Q2 24
$543.3M
$251.8M
Total Assets
MOFG
MOFG
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$6.2B
$511.5M
Q2 25
$6.2B
$513.1M
Q1 25
$6.3B
$519.4M
Q4 24
$6.2B
$534.0M
Q3 24
$6.6B
$374.1M
Q2 24
$6.6B
$374.4M
Debt / Equity
MOFG
MOFG
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.16×
0.14×
Q2 25
0.19×
0.13×
Q1 25
0.19×
0.13×
Q4 24
0.20×
0.13×
Q3 24
0.20×
0.21×
Q2 24
0.21×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MOFG
MOFG
PRCT
PRCT
Operating Cash FlowLast quarter
$17.7M
Free Cash FlowOCF − Capex
$16.7M
FCF MarginFCF / Revenue
27.3%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
1.04×
TTM Free Cash FlowTrailing 4 quarters
$109.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MOFG
MOFG
PRCT
PRCT
Q1 26
Q4 25
$-10.3M
Q3 25
$17.7M
$-6.6M
Q2 25
$24.9M
$-15.0M
Q1 25
$8.7M
$-17.0M
Q4 24
$63.2M
$-32.4M
Q3 24
$-2.8M
$-18.8M
Q2 24
$25.2M
$-15.7M
Free Cash Flow
MOFG
MOFG
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$16.7M
$-9.5M
Q2 25
$23.8M
$-17.8M
Q1 25
$8.3M
$-18.8M
Q4 24
$60.8M
$-33.6M
Q3 24
$-3.0M
$-19.0M
Q2 24
$24.6M
$-16.8M
FCF Margin
MOFG
MOFG
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
27.3%
-11.4%
Q2 25
39.5%
-22.5%
Q1 25
14.4%
-27.2%
Q4 24
124.2%
-49.2%
Q3 24
-7.9%
-32.6%
Q2 24
42.5%
-31.4%
Capex Intensity
MOFG
MOFG
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
1.5%
3.4%
Q2 25
1.9%
3.5%
Q1 25
0.7%
2.7%
Q4 24
4.9%
1.7%
Q3 24
0.6%
0.4%
Q2 24
1.1%
2.0%
Cash Conversion
MOFG
MOFG
PRCT
PRCT
Q1 26
Q4 25
Q3 25
1.04×
Q2 25
2.50×
Q1 25
0.57×
Q4 24
3.87×
Q3 24
Q2 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MOFG
MOFG

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons